How Darolutamide Plus Hormone Therapy Works for Men With Advanced Prostate Cancer in Everyday Medical Practice in Germany

Clinical trial NCT07395804 · RECRUITING

Trial details

NCT number: NCT07395804
Sponsor: Bayer
Status: RECRUITING
Study type: OBSERVATIONAL

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Start date: 2026-04-14
Primary completion: 2031-02-15
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.